Tomosynthesis Vs. Contrast-Enhanced Mammography in Women with Personal History of Breast Cancer in Western Pennsylvania

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,647

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

December 1, 2025

Study Completion Date

June 30, 2027

Conditions
Breast Cancer FemaleBreast CancerBreast NeoplasmsNeoplasms
Interventions
DEVICE

Contrast-enhanced mammogram

Contrast-enhanced mammography (CEM) is a new FDA-approved exam that is similar to magnetic resonance imaging (MRI) in depicting breast cancers due to increased and leaky blood vessels. Contrast-enhanced mammography is used as an adjunct following mammography and/or ultrasound examinations to localize a known or suspected lesion.

Trial Locations (3)

15146

Magee Womancare Monroeville, Monroeville

15213

Magee Womens Hospital, Pittsburgh

16066

Magee Womancare Passavant Cranberry, Cranberry Township

Sponsors
All Listed Sponsors
collaborator

Breast Cancer Research Foundation

OTHER

lead

Wendie Berg

OTHER